Previous studies have shown that C1q, the first recognition subcomponent of the complement classical pathway, comprises three chains (C1qA, C1qB, and C1qC) and exerts complex effects on tumorigenesis of multiple tumors, including prostate (55), and ovarian cancer (56) as well as gliomas (57). Here, C1QC is linked to central nervous system cancer.